Association of IRF5 gene polymorphisms with rheumatoid arthritis in a Tunisian population

References

• Klareskog L., Padyukov L., Ronnelid J., Alfredsson L. Genes, environment and immunity in the development of rheumatoid arthritis. Curr Opin Immunol 2006; 18: 650–5
   PubMed Web of Science ®Google Scholar
• Klareskog L., Stolt P., Lundberg K., Kallberg H., Bengtsson C., Grunewald J., et al. A new model for an etiology of rheumatoid arthritis: smoking may trigger HLA‐DR (shared epitope)‐restricted immune reactions to autoantigens modified by citrullination. Arthritis Rheum 2006; 54: 38–46
   PubMed Web of Science ®Google Scholar
• Seldin M. F., Amos C. I., Ward R., Gregersen P. K. The genetics revolution and the assault on rheumatoid arthritis. Arthritis Rheum 1999; 42: 1071–9
   PubMed Web of Science ®Google Scholar
• Hall F. C., Weeks D. E., Camilleri J. P., Williams L. A., Amos N., Darke C., et al. Influence of the HLA‐DRB1 locus on susceptibility and severity in rheumatoid arthritis. Q J Med 1996; 89: 821–9
   Google Scholar
• Lee H. S., Lee K. W., Song G. G., Kim H. A., Kim S. Y., Bae S. C. Increased susceptibility to rheumatoid arthritis in Koreans heterozygous for HLA‐DRB1*405 and *0901. Arthritis Rheum 2004; 50: 3468–75
   PubMed Web of Science ®Google Scholar
• Begovich A. B., Carlton V. E., Honigberg L. A., Schrodi S. J., Chokkalingam A. P., Alexander H. C., et al. A missense single‐nucleotide polymorphism in a gene encoding a protein tyrosine phosphatase (PTPN22) is associated with rheumatoid arthritis. Am J Hum Genet 2004; 75: 330–7
   PubMed Web of Science ®Google Scholar
• Ikari K., Momohara S., Inoue E., Tomatsu T., Hara M., Yamanaka H., et al. Haplotype analysis revealed no association between the PTPN22 gene and RA in a Japanese population. Rheumatology 2006; 45: 1345–8
   PubMed Web of Science ®Google Scholar
• Kawasaki E., Awata T., Ikegami H., Kobayashi T., Maruyama T., Nakanishi K., et al. Japanese Study Group on Type 1 Diabetes Genetics. Systematic search for single nucleotide polymorphisms in a lymphoid tyrosine phosphatase gene (PTPN22): association between a promoter polymorphism and type 1 diabetes in Asian populations. Am J Med Genet A 2006; 140: 586–93
   PubMed Web of Science ®Google Scholar
• Suzuki A., Yamada R., Chang X., Tokuhiro S., Sawada T., Suzuki M., et al. Functional haplotypes of PADI4, encoding citrullinating enzyme peptidylarginine deiminase 4, are associated with rheumatoid arthritis. Nat Genet 2003; 34: 395–402
   PubMed Web of Science ®Google Scholar
• Tokuhiro S., Yamada R., Chang X., Suzuki A., Kochi Y., Sawada T., et al. An intronic SNP in a RUNX1 binding site of SLC22A4, encoding an organic cation transporter, is associated with rheumatoid arthritis. Nat Genet 2003; 35: 341–8
   PubMed Web of Science ®Google Scholar
• Kochi Y., Yamada R., Suzuki A., Harley J. B., Shirasawa S., Sawada T., et al. A functional variant in FCRL3, encoding Fc receptor‐like 3, is associated with rheumatoid arthritis and several auto‐immunities. Nat Genet 2005; 37: 478–85
   PubMed Web of Science ®Google Scholar
• Plenge R. M., Padyukov L., Remmers E. F., Purcell S., Lee A. T., Karlson E. W., et al. Replication of putative candidate‐gene associations with rheumatoid arthritis in >4,000 samples from North America and Sweden: association of susceptibility with PTPN22, CTLA4, and PADI4. Am J Hum Genet 2005; 77: 1044–60
   PubMed Web of Science ®Google Scholar
• Barton A., Bowes J., Eyre S., Spreckley K., Hinks A., John S., et al. A functional haplotype of the PADI4 gene associated with rheumatoid arthritis in a Japanese population is not associated in a United Kingdom population. Arthritis Rheum 2004; 50: 1117–21
   PubMed Web of Science ®Google Scholar
• Mori M., Yamada R., Kobayashi K., Kawaida R., Yamamoto K. Ethnic differences in allele frequency of autoimmune‐disease‐associated SNPs. J Hum Genet 2005; 50: 264–6
   PubMed Web of Science ®Google Scholar
• Corporaal S., Bijl M., Kallenberg C. G. Familial occurrence of autoimmune diseases and auto‐antibodies in a Caucasian population of patients with systemic lupus erythematosus. Clin Rheumatol 2002; 21: 108–13
   PubMed Web of Science ®Google Scholar
• Lee Y. H., Rho Y. H., Choi S. J., Ji J. D., Song G. G., Nath S. K., et al. The PTPN22 C1858T functional polymorphism and autoimmune diseases: a meta‐analysis. Rheumatology (Oxford) 2007; 46: 49–56
   PubMed Web of Science ®Google Scholar
• Sigurdsson S., Nordmark G., Goring H. H., Lindroos K., Wiman A. C., Sturfelt G., et al. Polymorphisms in the tyrosine kinase 2 and interferon regulatory factor 5 genes are associated with systemic lupus erythematosus. Am J Hum Genet 2005; 7: 528–37
   Google Scholar
• Sigurdsson S., Padyukov L., Kurreeman F. A., Liljedahl U., Wiman A. C., Alfredsson L., et al. Association of a haplotype in the promoter region of the interferon regulatory factor 5 gene with rheumatoid arthritis. Arthritis Rheum 2007; 56: 2202–10
   PubMed Web of Science ®Google Scholar
• Ronnblom L. E., Alm G. V., Oberg K. E. Autoimmunity after alpha‐interferon therapy for malignant carcinoid tumors. Ann Intern Med 1991; 115: 178–83
   PubMed Web of Science ®Google Scholar
• Baechler E. C., Batliwalla F. M., Karypis G., Gaffney P. M., Ortmann W. A., Espe K. J., et al. Interferon‐inducible gene expression signature in peripheral blood cells of patients with severe lupus. Proc Natl Acad Sci USA 2003; 100: 2610–15
   PubMed Web of Science ®Google Scholar
• Van der Pouw Kraan T. C., Wijbrandts C. A., van Baarsen L. G., Voskuyl A. E., Rustenburg F., Baggen J. M., et al. Rheumatoid arthritis subtypes identified by genomic profiling of peripheral blood cells: assignment of a type I interferon signature in a subpopulation of patients. Ann Rheum Dis 2007; 66: 1008–14
   PubMed Web of Science ®Google Scholar
• Bave U., Nordmark G., Lovgren T., Ronnelid J., Cajander S., Eloranta M. L., et al. Activation of the type I interferon system in primary Sjögren's syndrome: a possible etiopathogenic mechanism. Arthritis Rheum 2005; 52: 1185–95
   PubMed Web of Science ®Google Scholar
• Van Baarsen L. G., van der Pouw Kraan T. C., Kragt J. J., Baggen J. M., Rustenburg F., Hooper T., et al. A subtype of multiple sclerosis defined by an activated immune defense program. Genes Immun 2006; 7: 522–31
   PubMed Web of Science ®Google Scholar
• Taniguchi T., Ogasawara K., Takaoka A., Tanaka N. IRF family of transcription factors as regulators of host defense. Annu Rev Immunol 2001; 19: 623–55
   PubMed Web of Science ®Google Scholar
• Mancl M. E., Hu G., Sangster‐Guity N., Olshalsky S. L., Hoops K., Fitzgerald‐Bocarsly P., et al. Two discrete promoters regulate the alternatively spliced human interferon regulatory factor‐5 isoforms. Multiple isoforms with distinct cell type‐specific expression, localization, regulation, and function. J Biol Chem 2005; 280: 21078–90
   PubMed Web of Science ®Google Scholar
• Barnes B. J., Moore P. A., Pitha P. M. Virus‐specific activation of a novel interferon regulatory factor, IRF‐5, results in the induction of distinct interferon alpha genes. J Biol Chem 2001; 276: 23382–90
   PubMed Web of Science ®Google Scholar
• Takaoka A., Yanai H., Kondo S., Duncan G., Negishi H., Mizutani T., et al. Integral role of IRF‐5 in the gene induction programme activated by Toll‐like receptors. Nature 2005; 434: 243–9
   PubMed Web of Science ®Google Scholar
• Dideberg V., Kristjansdottir G., Milani L., Libioulle C., Sigurdsson S., Louis E., et al. An insertion‐deletion polymorphism in the interferon regulatory factor 5 (IRF5) gene confers risk of inflammatory bowel diseases. Hum Mol Genet 2007; 16: 3008–16
   PubMed Web of Science ®Google Scholar
• Graham R. R., Kozyrev S. V., Baechler E. C., Reddy M. V., Plenge R. M., Bauer J. W., et al. A common haplotype of interferon regulatory factor 5 (IRF5) regulates splicing and expression and is associated with increased risk of systemic lupus erythematosus. Nat Genet 2006; 38: 550–5
   PubMed Web of Science ®Google Scholar
• Arnett F. C., Edworthy S. M., Bloch D. A., McShane D. J., Fries J. F., Cooper N. S., et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31: 315–24
   PubMed Web of Science ®Google Scholar
• Lathrop G. M. Estimating genotype relative risks. Tissue Antigens 1983; 22: 160–6
   PubMedGoogle Scholar
• Woolf B. On estimating the relation between blood group and disease. Ann Hum Genet 1995; 19: 251–3
   Google Scholar
• Garnier S., Dieude P., Michou L., Barbet S., Tan A., Lasbleiz S., et al. IRF5 rs2004640‐T allele, the new genetic factor for systemic lupus erythematosus, is not associated with rheumatoid arthritis. Ann Rheum Dis 2007; 66: 828–31
   PubMedGoogle Scholar
• Rueda B., Reddy M. V., González‐Gay M. A., Balsa A., Pascual‐Salcedo D., Petersson I. F., et al. Analysis of IRF5 gene functional polymorphisms in rheumatoid arthritis. Arthritis Rheum 2006; 54: 3815–19
   PubMedGoogle Scholar
• Schoenemeyer A., Barnes B. J., Mancl M. E., Latz E., Goutagny N., Pitha P. M., et al. The interferon regulatory factor, IRF5, is a central mediator of toll‐like receptor 7 signaling. J Biol Chem 2005; 280: 17005–12
   PubMed Web of Science ®Google Scholar
• Akira S., Uematsu S., Takeuchi O. Pathogen recognition and innate immunity. Cell 2006; 124: 783–801
   PubMed Web of Science ®Google Scholar
• Barnes B. J., Richards J., Mancl M., Hanash S., Beretta L., Pitha P. M. Global and distinct targets of IRF‐5 and IRF‐7 during innate response to viral infection. J Biol Chem 2004; 279: 45194–207
   PubMed Web of Science ®Google Scholar
• Barnes B. J., Kellum M. J., Field A. E., Pitha P. M. Multiple regulatory domains of IRF‐5 control activation, cellular localization, and induction of chemokines that mediate recruitment of T lymphocytes. Mol Cell Biol 2002; 22: 5721–40
   PubMed Web of Science ®Google Scholar
• Roelofs M. F., Joosten L. A., Abdollahi‐Roodsaz S., van Lieshout A. W., Sprong T., van den Hoogen F. H., et al. The expression of toll‐like receptors 3 and 7 in rheumatoid arthritis synovium is increased and costimulation of toll‐like receptors 3, 4, and 7/8 results in synergistic cytokine production by dendritic cells. Arthritis Rheum 2005; 52: 2313–22
   PubMed Web of Science ®Google Scholar